LIFECYCLE BIOTECHNOLOGIES, LLC – Trademark Portfolio
Entity Type: 16
LIFECYCLE BIOTECHNOLOGIES, LLC owns a portfolio of 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as DIFFUMAX, CHEM+NECT, CHEM+POUR, CHEM+PROTECT, and HELIX OSCILLATING BIOMIXER. Of these, 5 are registered. The portfolio spans 4 Nice Classification classes, led by Class 17 (Rubber Goods) and Class 1 (Chemicals). Headquartered in CLEBURNE, TX.
421 MARTI DRIVE
CLEBURNE, TX 76033
Showing of trademarks Trademarks
Trademark Classifications
LIFECYCLE BIOTECHNOLOGIES, LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does LIFECYCLE BIOTECHNOLOGIES, LLC have?
LIFECYCLE BIOTECHNOLOGIES, LLC has 5 U.S. trademarks filed with the USPTO. Of these, 5 registered.
What trademark classes does LIFECYCLE BIOTECHNOLOGIES, LLC file in?
LIFECYCLE BIOTECHNOLOGIES, LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 17 (Rubber Goods), Class 1 (Chemicals), Class 9 (Computers & Electronics), Class 20 (Furniture). Class 17 covers unprocessed and semi-processed rubber, gutta-percha, gum, asbestos, mica.
What are LIFECYCLE BIOTECHNOLOGIES, LLC's most well-known trademarks?
LIFECYCLE BIOTECHNOLOGIES, LLC's registered trademark portfolio includes well-known marks such as DIFFUMAX, CHEM+NECT, CHEM+POUR, CHEM+PROTECT, and HELIX OSCILLATING BIOMIXER. These are among 5 currently registered trademarks in the portfolio.
What is LIFECYCLE BIOTECHNOLOGIES, LLC's trademark registration success rate?
LIFECYCLE BIOTECHNOLOGIES, LLC has a 100% trademark registration rate, with 5 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.